Applied Molecular Q3 EPS $(0.17) Beats $(0.50) Estimate
Portfolio Pulse from Benzinga Newsdesk
Applied Molecular (NASDAQ:AMTI) reported Q3 losses of $(0.17) per share, beating the analyst consensus estimate of $(0.50) by 66 percent. This represents a 73.85 percent increase over losses of $(0.65) per share from the same period last year.
November 09, 2023 | 9:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied Molecular's Q3 earnings beat analyst estimates by a significant margin, which could positively impact the stock in the short term.
Applied Molecular's Q3 earnings beat analyst estimates by a significant margin. This is generally seen as a positive signal by the market and could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100